Cargando…

Bivalent Human Papillomavirus Vaccine Effectiveness in a Japanese Population: High Vaccine-Type–Specific Effectiveness and Evidence of Cross-Protection

BACKGROUND: Proactive recommendations for human papillomavirus (HPV) vaccines in Japan have been suspended for 5 years because of safety concerns. While no scientific evidence exists to substantiate these concerns, one reason given for not reinstating recommendations is the lack of reliable vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kudo, Risa, Yamaguchi, Manako, Sekine, Masayuki, Adachi, Sosuke, Ueda, Yutaka, Miyagi, Etsuko, Hara, Megumi, Hanley, Sharon J B, Enomoto, Takayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325350/ https://www.ncbi.nlm.nih.gov/pubmed/30299519 http://dx.doi.org/10.1093/infdis/jiy516

Ejemplares similares

Differential misclassification between self-reported status and official HPV vaccination records in Japan: Implications for evaluating vaccine safety and effectiveness
por: Yamaguchi, Manako, et al.
Publicado: (2018)

Effectiveness of human papillomavirus vaccine against cervical precancer in Japan: Multivariate analyses adjusted for sexual activity
por: Kudo, Risa, et al.
Publicado: (2022)

Long-Term Effects of Human Papillomavirus Vaccination in Clinical Trials and Real-World Data: A Systematic Review
por: Kurosawa, Megumi, et al.
Publicado: (2022)

Epidemiologic Profile of Type-Specific Human Papillomavirus Infection after Initiation of HPV Vaccination
por: Sekine, Masayuki, et al.
Publicado: (2020)

Suspension of proactive recommendations for HPV vaccination has led to a significant increase in HPV infection rates in young Japanese women: real-world data
por: Sekine, Masayuki, et al.
Publicado: (2021)

Internet Survey of Awareness and Behavior Related to HPV Vaccination in Japan
por: Kudo, Risa, et al.
Publicado: (2021)

Japan’s Ongoing Crisis on HPV Vaccination
por: Sekine, Masayuki, et al.
Publicado: (2020)

Long‐term effectiveness of HPV vaccination against HPV infection in young Japanese women: Real‐world data
por: Kurosawa, Megumi, et al.
Publicado: (2022)

Risk factors for HPV infection and high-grade cervical disease in sexually active Japanese women
por: Yamaguchi, Manako, et al.
Publicado: (2021)

Effect of a Brief Web-Based Educational Intervention on Willingness to Consider Human Papillomavirus Vaccination for Children in Japan: Randomized Controlled Trial
por: Suzuki, Yukio, et al.
Publicado: (2021)

The Effect of a Web-Based Cervical Cancer Survivor’s Story on Parents' Behavior and Willingness to Consider Human Papillomavirus Vaccination for Daughters: Randomized Controlled Trial
por: Suzuki, Yukio, et al.
Publicado: (2022)

Cervical Cancer Protection in Japan: Where Are We?
por: Yagi, Asami, et al.
Publicado: (2021)

Human papillomavirus vaccine to prevent cervical intraepithelial neoplasia in Japan: A nationwide case‐control study
por: Ikeda, Sayaka, et al.
Publicado: (2020)

The looming health hazard: A wave of HPV-related cancers in Japan is becoming a reality due to the continued suspension of the governmental recommendation of HPV vaccine
por: Yagi, Asami, et al.
Publicado: (2021)

Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
por: Bogaards, Johannes A, et al.
Publicado: (2019)

Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine: Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule
por: Hoes, Joske, et al.
Publicado: (2021)

Potential for cervical cancer incidence and death resulting from Japan’s current policy of prolonged suspension of its governmental recommendation of the HPV vaccine
por: Yagi, Asami, et al.
Publicado: (2020)

A nationwide birth year‐by‐year analysis of effectiveness of HPV vaccine in Japan
por: Yagi, Asami, et al.
Publicado: (2021)

Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS Study
por: Mimura, Wataru, et al.
Publicado: (2023)

Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination Against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients
por: Woestenberg, Petra J, et al.
Publicado: (2020)

Randomized Controlled Clinical Trial of Bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian Children
por: Tagbo, Beckie N, et al.
Publicado: (2020)

Dynamic changes in Japan’s prevalence of abnormal findings in cervical cytology depending on birth year
por: Ueda, Yutaka, et al.
Publicado: (2018)

Author Correction: Dynamic changes in Japan’s prevalence of abnormal findings in cervical cytology depending on birth year
por: Ueda, Yutaka, et al.
Publicado: (2018)

Intentions for catch-up HPV vaccination in Japan: an internet survey
por: Nakagawa, Satoshi, et al.
Publicado: (2023)

Predicting the Public Health Impact of Bivalent Vaccines and Nirmatrelvir-Ritonavir Against Coronavirus Disease 2019
por: Park, Hailey J, et al.
Publicado: (2023)

Vaccinating Women Previously Exposed to Human Papillomavirus: A Cost-Effectiveness Analysis of the Bivalent Vaccine
por: Turner, Hugo C., et al.
Publicado: (2013)

Can Catch-Up Vaccinations Fill the Void Left by Suspension of the Governmental Recommendation of HPV Vaccine in Japan?
por: Yagi, Asami, et al.
Publicado: (2022)

Impact and Cost-effectiveness of Selective Human Papillomavirus Vaccination of Men Who Have Sex With Men
por: Lin, Allen, et al.
Publicado: (2017)

Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan
por: Anwari, Palwasha, et al.
Publicado: (2020)

Importance of Education about Cervical Cancer and Its Preventive Measures for the Promotion of HPV Vaccine According to the WHO Strategies
por: Ueda, Yutaka, et al.
Publicado: (2021)

Safety and Immunogenicity of Sabin Strain Inactivated Poliovirus Vaccine Compared With Salk Strain Inactivated Poliovirus Vaccine, in Different Sequential Schedules With Bivalent Oral Poliovirus Vaccine: Randomized Controlled Noninferiority Clinical Trials in China
por: Hu, Yuemei, et al.
Publicado: (2019)

Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials( )
por: Gast, Christopher, et al.
Publicado: (2021)

Cellular Immune Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent HPV Vaccine in Fijian Girls and Subsequent Responses to a Dose of Bivalent HPV Vaccine
por: Toh, Zheng Quan, et al.
Publicado: (2018)

Cost-Effectiveness Analysis of the Bivalent and Quadrivalent Human Papillomavirus Vaccines from a Societal Perspective in Colombia
por: Aponte-González, Johanna, et al.
Publicado: (2013)

Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial
por: Panagiotou, Orestis A, et al.
Publicado: (2015)

Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands
por: Schurink‐van ’t Klooster, Tessa M., et al.
Publicado: (2023)

Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model
por: Jit, Mark, et al.
Publicado: (2011)

Japanese Mothers’ Intention to HPV Vaccinate Their Daughters: How Has It Changed over Time Because of the Prolonged Suspension of the Governmental Recommendation?
por: Yagi, Asami, et al.
Publicado: (2020)

Omicron Variant-Specific Serological Imprinting Following BA.1 or BA.4/5 Bivalent Vaccination and Previous SARS-CoV-2 Infection: A Cohort Study
por: Baerends, Eva A M, et al.
Publicado: (2023)

Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors
por: Woestenberg, Petra J, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9vl5jpficl5qb1hslk6le52m21